Icosavax (NASDAQ:ICVX) Stock Rating Reaffirmed by William Blair

William Blair reaffirmed their outperform rating on shares of Icosavax (NASDAQ:ICVX – Free Report) in a research note published on Wednesday morning, RTT News reports. William Blair also issued estimates for Icosavax’s Q4 2023 earnings at ($0.55) EPS, FY2023 earnings at ($2.17) EPS, Q1 2024 earnings at ($0.55) EPS, Q2 2024 earnings at ($0.54) EPS, […]

Leave a Reply

Your email address will not be published.

Previous post Piper Sandler Cuts Gamida Cell (NASDAQ:GMDA) Price Target to $2.00
Next post 5 takeaways from the Chicago Bulls’ 103-97 loss to the Orlando Magic, dropping them to 0-2 in the In-Season Tournament